Skip to content

Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain

Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain: a Randomized Control Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06565520
Enrollment
50
Registered
2024-08-22
Start date
2024-04-24
Completion date
2025-04-21
Last updated
2024-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome

Brief summary

This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks in individuals with PFP. The objective is the explore if having tDCS target the area of the brain controlling hip muscles, when paired with exercise, will be more effective in reducing the amount the knee caves in for individuals with PFP versus those who receive exercise alone as their treatment. The aim is to contribute our findings to the growing knowledge in this area in order to help establish the possibility, and feasibility, of its use in clinical settings to strengthen traditional treatments for this patient population.

Interventions

The total amount of participation time per qualified subject will be approximately 150 minutes over two sessions. The participant screening session will take approximately 30 minutes, which is an appropriate amount of time to complete all screening tasks. The tDCS and sham sessions will take approximately a total of 120 minutes over two sessions. The first session will include a screening (30 minutes) to ensure they qualify for the study, followed by a treatment session (60 minutes): including non-invasive brain stimulation combined with hip strengthening exercises and functional movement testing at UNLV Maryland Campus. Subjects will return for a second treatment session (60 minutes) 2 weeks after the first.

Sponsors

University of Nevada, Las Vegas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. are between 18 and 45 years old 2. have had patellofemoral pain (PFP; kneecap pain) on one side for at least 3 months, and 3) the knee does cave in when performing functional movements.

Exclusion criteria

1. do not have pain coming from the kneecap during screening; 2. have a history of knee injury or surgery, 3. have a history of seizures and/or taking anti-seizure medication, 4. have an implanted device that interacts with electric current, 5. have a history of balance disorder, 6. currently are pregnant or think they may be pregnant.

Design outcomes

Primary

MeasureTime frame
trunk lean angleBaseline and Immediately after intervention
knee frontal plane projection angleBaseline and Immediately after intervention
hip frontal plane projection angleBaseline and Immediately after intervention
dynamic valgus indexBaseline and Immediately after intervention

Countries

United States

Contacts

Primary ContactKai Yu Ho, PhD
kaiyu.ho@unlv.edu7028952629

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026